NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 283 filers reported holding NEOGENOMICS INC in Q1 2022. The put-call ratio across all filers is 0.92 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $52 | -21.2% | 4,216 | +2.1% | 0.00% | – |
| Q2 2023 | $66 | -9.6% | 4,129 | -1.1% | 0.00% | – |
| Q1 2023 | $73 | +102.8% | 4,174 | +6.4% | 0.00% | – |
| Q4 2022 | $36 | -99.8% | 3,924 | +115.8% | 0.00% | – |
| Q3 2022 | $16,000 | +300.0% | 1,818 | +304.0% | 0.00% | – |
| Q2 2022 | $4,000 | -80.0% | 450 | -73.0% | 0.00% | – |
| Q1 2022 | $20,000 | 0.0% | 1,667 | +190.4% | 0.00% | – |
| Q4 2021 | $20,000 | -33.3% | 574 | -75.6% | 0.00% | -100.0% |
| Q4 2018 | $30,000 | – | 2,350 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 1,046,639 | $12,874 | 8.15% |
| Greenhouse Funds LLLP | 3,981,003 | $48,966,337 | 3.62% |
| First Light Asset Management, LLC | 3,028,913 | $37,255,630 | 3.54% |
| PERKINS CAPITAL MANAGEMENT INC | 193,950 | $2,386 | 2.36% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,557,895 | $19,162,109 | 1.16% |
| EMERALD ADVISERS, LLC | 1,927,074 | $23,703,005 | 1.15% |
| Bullseye Asset Management LLC | 163,792 | $2,015 | 1.12% |
| FORMULA GROWTH LTD | 208,885 | $2,569,286 | 0.88% |
| OAK FAMILY ADVISORS, LLC | 96,737 | $1,189,865 | 0.56% |
| Parkman Healthcare Partners LLC | 245,812 | $3,023,488 | 0.55% |